Logo Logo Logo
  • Home
  • About Us
    • Organization
    • Members
    • Contact Us
  • Research & Publications
    • Therapeutics Letter
    • Drug Assessments
    • PharmacoEpidemiology
    • Blog
  • Prescribing Portraits
    • Register
  • Continuing Education
    • Events & Webinars
    • Podcasts & Videos
  • Subscribe
  • Donate
Logo Logo Logo Logo Logo Logo
  • Home
  • About Us
    • Organization
    • Members
    • Contact Us
  • Research & Publications
    • Therapeutics Letter
    • Drug Assessments
    • PharmacoEpidemiology
    • Blog
  • Prescribing Portraits
    • Register
  • Continuing Education
    • Events & Webinars
    • Podcasts & Videos
  • Subscribe
  • Donate
 

mirtazapina Tag

06 May [129] Mirtazapina: Actualización de su eficacia, seguridad, dosis-respuesta

Posted at 18:02h in Therapeutics Letter-ES 0 Comments
Share

Poco después de que la mirtazapina fuera autorizada en Canadá, un número de Therapeutics Letter de 2002 concluía que no presentaba una mejor eficacia o seguridad respecto a otros antidepresivos.1 La mirtazapina fue aprobada para...

Read More

adherencia a la medicación agentes antibacterianos agentes broncodilatadores anticolinérgicos antidepresivos análisis de costo-beneficio buprenorfina cambio climático cannabinoides codeína costos de medicamentos covid-19 daño deprescribiendo desprescripción Diabetes división de comprimidos dolor dolor crónico dolor neuropático efectos adversos efectos secundarios y reacciones adversas relacionados con medicamentos EPOC factores de riesgo gabapentina IBP infecciones del tracto urinario inhaladores de polvo seco Inhibidores de la Bomba de Protones ITU Nirmatrelvir opioides Orkambi Paxlovid prediabetes pregabalina revisión sistemática Ritonavir seguridad seguridad del paciente servicios de salud preventiva sobrediagnóstico terapia combinada de fármacos Tmax tramadol

Therapeutics Initiative logo

Our mission is to provide physicians, nurse practitioners, pharmacists, allied health professionals, and the public with up-to-date, independent, evidence-based, practical information on healthcare interventions. More about us

The Therapeutics Initiative is part of the Department of Anesthesiology, Pharmacology & Therapeutics at UBC's Faculty of Medicine.

Donate

 

Contact

Therapeutics Initiative
Dept of Anesthesiology, Pharmacology & Therapeutics
Faculty of Medicine
University of British Columbia

300 - 2176 Health Sciences Mall
Vancouver, BC, Canada V6T 1Z3

210 - 1110 Government Street
Victoria, BC, Canada V8W 1Y2

Office: +1 604-822-0700
Send us a message

 

Subscribe for Updates

Want to stay abreast of new therapeutics information? Then subscribe to receive email notices of upcoming Therapeutics Letters, educational events, and other announcements. We promise not to spam you and you won’t hear from us more than a few times a month.

Subscribe

Located on the traditional, ancestral and unceded territory of the hən̓q̓əmin̓əm̓ speaking peoples, including the xʷməθkwəy̓əm (Musqueam), the Səl̓ílwətaʔ/Selilwitulh (Tsleil-Waututh), and the Skwxwú7mesh (Squamish) Nations, and on the lək̓ʷəŋən (Lekwungen) territory of the Songhees, Esquimalt and W̱SÁNEĆ peoples.

 
© Copyright 1994 - 2022 Therapeutics Initiative | Terms & Policies